MR-proADM test for use with clinical deterioration scores in cases of suspected infection
NICE guidance
Summary (source: NICE)
Reference: MIB195
Type: NICE guidance
Published: 11 October 2019
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
MR-proADM test for use with clinical deterioration scores in cases of suspected infection is nice guidance MIB195, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 11 October 2019. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.